Publications by authors named "Mitchell A Psotka"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

9,269

Total Likes

555

Extended Reach

587,842

Social Features

215
T
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.
Adriaan A Voors, Christiane E Angermann, John R Teerlink, Sean P Collins, Mikhail Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E Nassif, Mitchell A Psotka, Jasper Tromp

Nat Med· March 2022

Videos about Article: user user user

3 1 6 211 4 18

View All Article and Social Media Activity
F
Framework for Analytical Validation of DHT-Based Actigraphy and Signal Measures in HF Trials: The VALIDATE-HF Program.
Orhun Kose, Aymen Sahal, Guang K Zhang, Elite Possik, Mona Fiuzat, Mitchell A Psotka

JACC Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cardiogenic Shock Recovery Clinic.
Iyad N Isseh, Amika McBurnie, Ahmad A Abdul Aziz, Carolyn Rosner, Alexander G Truesdell, Mitchell A Psotka

J Card Fail· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where's the Remote? Failure to Report Clinical Workflows in Heart Failure Remote Monitoring Studies.
Elise L Shalowitz, Pardeep S Jhund, Mitchell A Psotka, Abhinav Sharma, Matthew G Dimond

J Card Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hierarchical Analysis of Composite Time-to-Event End Points in Heart Failure Clinical Trials Using Time in Clinical State.
Eric S Leifer, James F Troendle, Mitchell A Psotka, Vandana Sachdev

Circ Heart Fail· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure to Launch: Insights From Randomized Trials on Implementation Strategies for Guideline-Directed Therapies for Heart Failure.
Paula Rambarat, Adam D DeVore, Ankeet S Bhatt, Larry A Allen, Colleen K McIlvennan, Mitchell A Psotka

JACC Heart Fail· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low blood pressure and the effect of empagliflozin in acute heart failure: An EMPULSE analysis.
João Pedro Ferreira, Francisco Vasques-Nóvoa, Christiane E Angermann, Jan Biegus, Sean P Collins, Mitchell A Psotka

Eur J Heart Fail· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline-directed medical therapy implementation during hospitalization for cardiogenic shock.
Matthew G Dimond, Carolyn M Rosner, Seiyon Ben Lee, Unique Shakoor, Taraneh Samadani, Mitchell A Psotka

ESC Heart Fail· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trial.
Nina Nouhravesh, Stephen J Greene, Robert Clare, Daniel Wojdyla, Kevin J Anstrom, Mitchell A Psotka

Eur J Heart Fail· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responder Analyses Can Be Misleading.
Mary Ross Southworth, Mitchell A Psotka, Jordan E Pomeroy, Norman L Stockbridge

J Am Coll Cardiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Failure Drug Development Over the Eras: From the Heart Failure Collaboratory.
Vanessa Blumer, James L Januzzi, JoAnn Lindenfeld, Scott D Solomon, Mitchell A Psotka

JACC Heart Fail· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Risk Estimation of Adverse Events in Ambulatory LVAD Patients: A MOMENTUM 3 Analysis.
Palak Shah, Gabriel Sayer, Shashank S Sinha, Manreet K Kanwar, Jennifer A Cowger, Mitchell A Psotka

JACC Heart Fail· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence in Cardiovascular Clinical Trials.
Jonathan W Cunningham, William T Abraham, Ankeet S Bhatt, Jessilyn Dunn, G Michael Felker, Mitchell A Psotka

J Am Coll Cardiol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension.
Jason Weatherald, Thomas R Fleming, Martin R Wilkins, Thomas M Cascino, Mitchell A Psotka

Eur Respir J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE.
João Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, Mikhail N Kosiborod, Christiane E Angermann, Mitchell A Psotka

Eur J Heart Fail· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension.
Roham T Zamanian, Jason Weatherald, Andrew J Sweatt, Anna Hemnes, Moira Rashid, Mitchell A Psotka

Am J Respir Crit Care Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Jasper Tromp, Mikhail N Kosiborod, Christiane E Angermann, Sean P Collins, John R Teerlink, Mitchell A Psotka

Eur J Heart Fail· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping.
Matthew G Dimond, Nasrien E Ibrahim, Mona Fiuzat, John J V McMurray, JoAnn Lindenfeld, Mitchell A Psotka

JACC Heart Fail· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking the Nomenclature of Heart Failure Cardiogenic Shock: Do We Need to Start De Novo?
Vanessa Blumer, Manreet K Kanwar, Mitchell A Psotka

Circ Heart Fail· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary approach to cardiogenic shock care: a state-of-the-art review.
Aditya Mehta, Ilan Vavilin, Andrew H Nguyen, Wayne B Batchelor, Vanessa Blumer, Mitchell A Psotka

Front Cardiovasc Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper.
Anuradha Lala, Carine E Hamo, Biykem Bozkurt, Mona Fiuzat, Vanessa Blumer, Mitchell A Psotka

JACC Heart Fail· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking heart failure clinical trials: the heart failure collaboratory.
Mutaz Alkalbani, Mitchell A Psotka

Front Cardiovasc Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Step by Step: Really Need It in Our World.
Mitchell A Psotka

JACC Heart Fail· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSE.
João Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, Mikhail N Kosiborod, Christiane E Angermann, Mitchell A Psotka

Eur J Heart Fail· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart failure without a reduced ejection fraction.
Sant Kumar, Mitchell A Psotka

Am J Manag Care· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Stephen J Greene, Eric J Velazquez, Kevin J Anstrom, Robert M Clare, Tracy A DeWald, Mitchell A Psotka

Circulation· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis